HypeCheck
← All Ingredients Digestive

Last verified: today

Dipeptidyl Peptidase IV (DPP-IV) Inhibition

Also known as: DPP-4, DPP-IV, dipeptidyl peptidase-4, DPP4 inhibitor, gliptin

Evidence under review. — Not yet rated

Enzyme target for diabetes drugs. Inhibiting DPP-IV lowers blood sugar safely in type 2 diabetes.

  • What it does

    DPP-IV is an enzyme in the body that breaks down hormones called incretins, which help regulate blood sugar after meals. Prescription drugs called 'gliptins' (like sitagliptin, saxagliptin,...

  • Evidence quality

    Evidence base hasn't been formally rated yet. See research below.

  • Clinical dose

    Varies by drug: sitagliptin 100mg, saxagliptin 5mg, anagliptin 100mg twice daily, evogliptin 5mg (prescription medications only)

See full breakdown ↓ Methodology →

What the Science Says

DPP-IV is an enzyme in the body that breaks down hormones called incretins, which help regulate blood sugar after meals. Prescription drugs called 'gliptins' (like sitagliptin, saxagliptin, anagliptin, and evogliptin) block this enzyme, allowing incretins to stay active longer and stimulate insulin release. Multiple clinical trials show these drugs reduce HbA1c by roughly 0.55–0.83% when added to other diabetes medications, with a low risk of dangerous low blood sugar.

What It Doesn't Do

DPP-IV inhibition is not a supplement — the gliptin drugs are prescription-only medications. Food-derived peptides that inhibit DPP-IV in lab tests have not been proven to lower blood sugar in humans. No over-the-counter supplement has demonstrated meaningful DPP-IV inhibition in clinical trials. This is not a weight-loss tool. It does not replace insulin in type 1 diabetes.

Evidence-Based Benefits

DPP-IV inhibitor drugs reduce HbA1c by ~0.6–0.8% when added to metformin in type 2 diabetes.

Strong Evidence

Effective at: Varies by drug (e.g., evogliptin 5mg, anagliptin 100mg twice daily)

Supporting studies (click to view on PubMed):

PMID 42036072 PMID 37750183 PMID 41381685

DPP-IV inhibitors improve pancreatic beta-cell function as measured by HOMA-β in type 2 diabetes.

Moderate Evidence

Effective at: Anagliptin 100mg twice daily; evogliptin 5mg/day

Supporting studies (click to view on PubMed):

PMID 42036072 PMID 37750183

Adding sitagliptin to insulin therapy improves blood sugar control in hospitalized type 2 diabetes patients.

Moderate Evidence

Effective at: Sitagliptin 100mg/day

Supporting studies (click to view on PubMed):

PMID 38581842

In animal studies, the DPP-IV inhibitor alogliptin reduced diabetes-related brain inflammation and memory impairment.

Weak Evidence

Effective at: 20–40 mg/kg/day in rats (no human dose established)

Supporting studies (click to view on PubMed):

PMID 42269219

Absorption & Bioavailability

Unknown for food-derived DPP-IV inhibitors. Prescription gliptin drugs have well-characterized oral bioavailability established in pharmaceutical trials, but this data was not provided in the reviewed papers.

Red Flags to Watch For

  • DPP-IV inhibitor drugs are prescription medications — any supplement claiming to 'inhibit DPP-IV' is making an unproven drug-like claim
  • In vitro (lab dish) DPP-IV inhibition by food peptides or nanoparticles does NOT mean the effect works in humans — no clinical evidence provided for these
  • Combining DPP-IV inhibitors with insulin or other diabetes drugs requires medical supervision due to hypoglycemia risk
  • Green-synthesized nanoparticles (zinc oxide, silver) showing DPP-IV inhibition in lab tests have unknown safety profiles and no human trial data

Frequently Asked Questions

What does Dipeptidyl Peptidase IV (DPP-IV) Inhibition do?

Enzyme target for diabetes drugs. Inhibiting DPP-IV lowers blood sugar safely in type 2 diabetes.

What is the effective dose of Dipeptidyl Peptidase IV (DPP-IV) Inhibition?

Varies by drug: sitagliptin 100mg, saxagliptin 5mg, anagliptin 100mg twice daily, evogliptin 5mg (prescription medications only)

Is Dipeptidyl Peptidase IV (DPP-IV) Inhibition safe?

DPP-IV inhibitor drugs are prescription medications — any supplement claiming to 'inhibit DPP-IV' is making an unproven drug-like claim

What doesn't Dipeptidyl Peptidase IV (DPP-IV) Inhibition do?

DPP-IV inhibition is not a supplement — the gliptin drugs are prescription-only medications.

Research Sources

  • PubMed
  • NIH DSLD

This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-07-06